It might be particularly interesting to study this receptor and its regulation in the context of autoimmune and metabolic diseases (e.g., Type 1 and Type 2 diabetes) given the common anti-inflammatory action of LGR4 in different tissues as well as its emerging role in metabolism. This evidence concerns the gene LGR4 and Other metabolic disease.